Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03095612
Title Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
University of Pittsburgh Medical Center-Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
University of Vanderbilt Medical Center-Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75063 United States Details
University of Washington-Seattle Cancer Care Alliance Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field